David Hyungjun Yi, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 19 Village Sq, Chelmsford, MA 01824 Phone: 978-256-5600 Fax: 978-703-0250 |
Stephen Joseph Poor Iii, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 17 Village Sq, Chelmsford, MA 01824 Phone: 978-250-8001 Fax: 978-250-4142 |
David George Perkins, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 19 Village Sq, Chelmsford, MA 01824 Phone: 978-256-5600 Fax: 978-703-0250 |
David Mears Tracy, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 19 Village Sq, Chelmsford, MA 01824 Phone: 978-256-5600 Fax: 978-703-0250 |
Dr. Cecily Elaine Hamill, MD, PHD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 19 Village Sq, Chelmsford, MA 01824 Phone: 978-256-5600 Fax: 978-703-0250 |
James Kim, M.D., PH.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 19 Village Square, Chelmsford, MA 01824 Phone: 978-256-5600 Fax: 978-703-0250 |
Glen Alan Bolliger, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 19 Village Sq, Chelmsford, MA 01824 Phone: 978-256-5600 Fax: 978-703-0250 |
Murat Veysel Kalayoglu, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 18 Village Square, Massachusetts Eye Associates, P.c, Chelmsford, MA 01824 Phone: 978-256-5600 Fax: 978-703-0250 |
News Archive
In a recent study published by the Journal of Pain, co-authored by Elizabeth Losin, assistant professor of psychology and director of the Social and Cultural Neuroscience lab at the University of Miami, researchers found that a patient's pain responses may be perceived differently by others based on their gender.
Lifeline Vascular Access(SM), the nation's leading provider of vascular access management services, today announced that Dr. Stephen Osaguona has been awarded the 2009 Gerald A. Beathard Fellowship in Interventional Nephrology.
Vertex Pharmaceuticals Incorporated today announced positive interim results from an ongoing Phase 2 study designed to evaluate the safety and tolerability of INCIVEK (telaprevir) tablets in combination with pegylated-interferon and ribavirin in people who are co-infected with chronic genotype 1 hepatitis C (HCV) and human immunodeficiency virus.
The Westaim Corporation (Westaim or the Company) (TSX: "WED") announced today that, following the approval of the transaction by the shareholders of NUCRYST Pharmaceuticals Corp. (Nucryst), Westaim's wholly-owned subsidiary, 1499642 Alberta Ltd. (1499642), amalgamated (the Amalgamation) with Nucryst to form a new company under the name "Westaim Holdings Limited" (Westaim Holdings).
Sex workers face discrimination within healthcare settings that limit their access to safe care. Researchers at the University of Illinois Chicago's College of Nursing have recently published a paper demonstrating how patient-centered care for sex workers could be implemented.
› Verified 5 days ago